跳到正文

Retension Pharmaceuticals, Inc.(RTSN)内部人交易:高管与董事近期交易

过去 18 个月,共有 6 位内部人为 Retension Pharmaceuticals, Inc.(RTSN)报告了 12 笔 Form 4 交易(最近一笔 2026-10-13)。

日期内部人职务类型股数市值
2026-10-13BERENDT MICHAEL J董事买入4,026$0
2026-10-13BERGER FRANKLIN M董事买入12,517$0
2026-10-13Olds Donald董事买入5,637$0
2026-10-13Bisson SabineCHIEF OPERATING OFFICER买入1,611$0
2026-10-13Keller Eric L.CHIEF EXECUTIVE OFFICER买入20,800$249,600
2026-10-13Sweetnam PaulCHIEF SCIENTIFIC OFFICER买入4,026$0
2026-10-13BERENDT MICHAEL J董事买入2,640$0
2026-10-13BERGER FRANKLIN M董事买入10,000$120,000
2026-10-13Bisson SabineCHIEF OPERATING OFFICER买入2,504$0
2026-10-13Keller Eric L.CHIEF EXECUTIVE OFFICER买入9,662$0
2026-10-13Sweetnam PaulCHIEF SCIENTIFIC OFFICER买入2,640$0
2026-10-13Keller Eric L.CHIEF EXECUTIVE OFFICER买入31,368$0

来源:SEC Form 4 申报文件 · 截至 2026-10-13